Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIIIW) EBIT Margin (2020 - 2025)

P3 Health Partners' EBIT Margin history spans 6 years, with the latest figure at 39.98% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 262.0% year-over-year to 39.98%; the TTM value through Dec 2025 reached 18.53%, up 285.0%, while the annual FY2025 figure was 18.53%, 285.0% up from the prior year.
  • EBIT Margin reached 39.98% in Q4 2025 per PIIIW's latest filing, down from 12.81% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 28.72% in Q4 2021 to a low of 848.83% in Q1 2021.
  • Average EBIT Margin over 5 years is 82.2%, with a median of 17.08% recorded in 2021.
  • The largest YoY upside for EBIT Margin was 82975bps in 2022 against a maximum downside of -33401bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 28.72% in 2021, then plummeted by -824bps to 207.79% in 2022, then soared by 91bps to 18.53% in 2023, then tumbled by -102bps to 37.36% in 2024, then decreased by -7bps to 39.98% in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's EBIT Margin are 39.98% (Q4 2025), 12.81% (Q3 2025), and 9.59% (Q2 2025).